Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19
Ran Abuhasira, Irit Ayalon‐Dangur, Neta Zaslavsky, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 24

Showing 24 citing articles:

Sexual dimorphism in COVID-19: potential clinical and public health implications
Nicole Bechmann, Andreas Barthel, Andreas Schedl, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 3, pp. 221-230
Open Access | Times Cited: 105
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19
Zheng Zhu, Qingya Zeng, Qinyu Liu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2244652-e2244652
Open Access | Times Cited: 24
Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis
Jordan N. Keels, Isabella R. McDonald, Christopher S. Lee, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies
Zhi-Hui Song, Qiao-Ming Huang, Shan-Shan Xu, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 4, pp. 773-787
Closed Access | Times Cited: 3
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review
Kamyar Asadipooya, Artin Asadipooya, Reuben Adatorwovor
Archives of Virology (2024) Vol. 169, Iss. 6
Closed Access | Times Cited: 3
Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes
Andreana Foresta, Luisa Ojeda‐Fernández, Giulia Macaluso, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 4, pp. e115-e126
Open Access | Times Cited: 9
Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
Yingjia Yao, Yunhan Zhang, Zexu Li, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 675, pp. 113-121
Open Access | Times Cited: 4
The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
Niya Narayanan, Dukhabandhu Naik, Jayaprakash Sahoo, et al.
World Journal of Virology (2022) Vol. 11, Iss. 6, pp. 399-410
Open Access | Times Cited: 7
Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview
Anna Gorący, Jakub Rosik, Bartosz Szostak, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 5
VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission
Ewa Pius‐Sadowska, Piotr Kulig, Anna Niedźwiedź, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17003-17003
Open Access | Times Cited: 2
Impact of Antidiabetic Drugs on Clinical Outcomes of COVID-19: A Nationwide Population-Based Study
Han Na Jang, Sun Joon Moon, Jin‐Hyung Jung, et al.
Endocrinology and Metabolism (2024)
Open Access
Impact of Antidiabetic Drugs on Clinical Outcomes of COVID-19: A Nationwide Population-Based Study
Han Na Jang, Sun Joon Moon, Jin‐Hyung Jung, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 479-488
Open Access
Drug Repurposing for COVID-19 Therapy: Pipeline, Current Status and Challenges
Rohit Verma, Shivani Raj, Umang Berry, et al.
(2023), pp. 451-478
Closed Access | Times Cited: 1
A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
Yingjia Yao, Yunhan Zhang, Zexu Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Е.А. Карасева, В. А. Мартынов, Т. Е. Филатова, et al.
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 11, pp. 913-918
Open Access | Times Cited: 1
Ethnicity and risks of severe COVID‐19 outcomes associated with glucose‐lowering medications: A cohort study
Francesco Zaccardi, Pui San Tan, Carol Coupland, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 611-617
Open Access | Times Cited: 1
Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus
Pratiksha H. Roham, Jayesh Kamath, Shilpy Sharma
Advanced Biology (2023) Vol. 7, Iss. 8
Closed Access
Overview of Inpatient Management of Diabetes and COVID-19
Fuad Benyaminov, Patricia Garnica, Alyson K. Myers
Contemporary Endocrinology (2023), pp. 111-122
Closed Access
Glucose-Lowering Agents and COVID-19
Ah Reum Khang
Journal of Korean Diabetes (2022) Vol. 23, Iss. 1, pp. 1-6
Open Access
A simple nomogram for assessing COVID-19 in-hospital mortality in adults with diabetes: a retrospective cohort study
Zheng Zhu, Qinyu Liu, Qingya Zeng, et al.
Research Square (Research Square) (2022)
Open Access
Antidiabetic Drugs in COVID-19
Niki Katsiki, Maciej Banach
Contemporary cardiology (2022), pp. 351-364
Closed Access
Page 1

Scroll to top